Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis
Clinical trial NCT06039189 · COMPLETED
Trial details
- NCT number
- NCT06039189
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-24
- Primary completion
- 2025-04-14
- Enrollment
- 338
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.